Better Disease Control by Multidrug Regimen in Scabies: A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 212
- 主要终点
- Pruritus
研究概览
简要总结
Scabies is associated with significant discomfort and social taboo. Existing treatment regimen frequently fails due to lack of patient compliance. We compared single use regimen to existing standard repeat application regimen for treatment of scabies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 5 Years 至 80 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Willing patients
- •Clinical diagnosis of scabies
- •Within the age limits
排除标准
- •Unwilling patients
- •Patients with severe co-morbidities requiring long term medication
- •Pregnant women
- •Patients who don't fulfill the age limit criteria
研究组 & 干预措施
Group 1 Permethrin only
Standard regimen of permethrin 5% topical application to be repeated after 1 week.
干预措施: Permethrin Lotion 5% (Drug)
Group 2 Permethrin and Ivermectin
A combination regimen of permethrin 5% topical application with oral ivermectin 200 mcg/kg given on the single day only
干预措施: Permethrin Lotion 5% and Oral Ivermectin 200 mcg/kg (Drug)
结局指标
主要结局
Pruritus
时间窗: 1 month
Rate of relief from pruritus assessed using visual analog scale
次要结局
- Skin lesions(1 month)
研究者
Prajwal Pandey
Assistant Professor
B.P. Koirala Institute of Health Sciences
